EGFR regulates iron homeostasis to promote cancer growth through redistribution of transferrin receptor 1

Cancer Letters

Volumn 381, Issue 2, 2016, Pages 331-340

  Wang, Biao ^a   Zhang, Jiqin ^a   Song, Fei ^a   Tian, Mi ^a   Shi, Bizhi ^a   Jiang, Hua ^a   Xu, Wen ^a   Wang, Hai ^a   Zhou, Min ^a   Pan, Xiaorong ^a   Gu, Jianren ^a   Yang, Shengli ^a   Jiang, Liyan ^a   Li, Zonghai ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

EGFR; Iron homeostasis; TfR1; Tyrosine phosphorylation

Indexed keywords

CD71 ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR; EGFR PROTEIN, HUMAN; IRON; LEUKOCYTE ANTIGEN; PROTEIN KINASE INHIBITOR; TRANSFERRIN RECEPTOR;

ARTICLE; CANCER GROWTH; CELL CYCLE ARREST; CELL METABOLISM; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; IRON METABOLISM; IRON RESPONSIVE ELEMENT; IRON TRANSPORT; METABOLIC REGULATION; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TUMOR PROMOTION; A-549 CELL LINE; ADENOCARCINOMA; ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE CHECKPOINT; CYTOPLASM; DRUG EFFECTS; DRUG SCREENING; ENZYMOLOGY; FEMALE; GENETIC TRANSFECTION; GENETICS; HOMEOSTASIS; LUNG NEOPLASMS; METABOLISM; NUDE MOUSE; PATHOLOGY; TIME FACTOR;

A549 CELLS; ADENOCARCINOMA; ANIMALS; ANTIGENS, CD; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE CHECKPOINTS; CELL PROLIFERATION; CYTOPLASM; FEMALE; HOMEOSTASIS; HUMANS; IRON; LUNG NEOPLASMS; MICE, NUDE; PROTEIN KINASE INHIBITORS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, TRANSFERRIN; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84983268608     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2016.08.006     Document Type: Article

References (24)

1. [1] Arredondo, M., Nunez, M.T., Iron and copper metabolism. Mol. Aspects Med 26 (2005), 313–327.
2. [2] Whitnall, M., Howard, J., Ponka, P., Richardson, D.R., A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics. Proc. Natl. Acad. Sci. U.S.A. 103 (2006), 14901–14906.
3. [3] Torti, S.V., Torti, F.M., Ironing out cancer. Cancer Res 71 (2011), 1511–1514.
4. [4] Richardson, D.R., Ponka, P., The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. Biochim. Biophys. Acta 1331 (1997), 1–40.
5. [5] Lane, D.J., Bae, D.H., Merlot, A.M., Sahni, S., Richardson, D.R., Duodenal cytochrome b (DCYTB) in iron metabolism: an update on function and regulation. Nutrients 7 (2015), 2274–2296.
6. [6] Hentze, M.W., Muckenthaler, M.U., Andrews, N.C., Balancing acts: molecular control of mammalian iron metabolism. Cell 117 (2004), 285–297.
7. [7] Levy, J.E., Jin, O., Fujiwara, Y., Kuo, F., Andrews, N.C., Transferrin receptor is necessary for development of erythrocytes and the nervous system. Nat. Genet 21 (1999), 396–399.
8. [8] Xiong, W., Wang, L., Yu, F., Regulation of cellular iron metabolism and its implications in lung cancer progression. Med. Oncol, 31, 2014, 28.
9. [9] Chanvorachote, P., Luanpitpong, S., Iron induces cancer stem cells and aggressive phenotypes in human lung cancer cells. Am. J. Physiol. Cell Physiol 310 (2016), C728–C739.
10. [10] Zhang, C., Zhang, F., Iron homeostasis and tumorigenesis: molecular mechanisms and therapeutic opportunities. Protein Cell 6 (2015), 88–100.
11. [11] Walker, R.A., Day, S.J., Transferrin receptor expression in non-malignant and malignant human breast tissue. J. Pathol 148 (1986), 217–224.
12. [12] Soyer, H.P., Smolle, J., Torne, R., Kerl, H., Transferrin receptor expression in normal skin and in various cutaneous tumors. J. Cutan. Pathol 14 (1987), 1–5.
13. [13] Yarden, Y., Sliwkowski, M.X., Untangling the ErbB signalling network. Nat. Rev. Mol. Cell Biol 2 (2001), 127–137.
14. [14] Jian, J., Yang, Q., Huang, X., Src regulates Tyr(20) phosphorylation of transferrin receptor-1 and potentiates breast cancer cell survival. J. Biol. Chem 286 (2011), 35708–35715.
15. [15] Park, E.J., Min, H.Y., Chung, H.J., Hong, J.Y., Kang, Y.J., Hung, T.M., et al. Down-regulation of c-Src/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells. Cancer Lett 277 (2009), 133–140.
16. [16] Lui, V.W., Grandis, J.R., EGFR-mediated cell cycle regulation. Anticancer Res 22 (2002), 1–11.
17. [17] Pike, L.J., Growth factor receptors, lipid rafts and caveolae: an evolving story. Biochim. Biophys. Acta 1746 (2005), 260–273.
18. [18] Warren, R.A., Green, F.A., Stenberg, P.E., Enns, C.A., Distinct saturable pathways for the endocytosis of different tyrosine motifs. J. Biol. Chem 273 (1998), 17056–17063.
19. [19] Warren, R.A., Green, F.A., Enns, C.A., Saturation of the endocytic pathway for the transferrin receptor does not affect the endocytosis of the epidermal growth factor receptor. J. Biol. Chem 272 (1997), 2116–2121.
20. [20] Tosoni, D., Puri, C., Confalonieri, S., Salcini, A.E., De Camilli, P., Tacchetti, C., et al. TTP specifically regulates the internalization of the transferrin receptor. Cell 123 (2005), 875–888.
21. [21] Torti, S.V., Torti, F.M., Iron and cancer: more ore to be mined. Nat. Rev. Cancer 13 (2013), 342–355.
22. [22] Malumbres, M., Barbacid, M., Cell cycle, CDKs and cancer: a changing paradigm. Nat. Rev. Cancer 9 (2009), 153–166.
23. [23] Kukulj, S., Jaganjac, M., Boranic, M., Krizanac, S., Santic, Z., Poljak-Blazi, M., Altered iron metabolism, inflammation, transferrin receptors, and ferritin expression in non-small-cell lung cancer. Med. Oncol 27 (2010), 268–277.
24. [24] Sattar, N., Scott, H.R., McMillan, D.C., Talwar, D., O'Reilly, D.S., Fell, G.S., Acute-phase reactants and plasma trace element concentrations in non-small cell lung cancer patients and controls. Nutr. Cancer 28 (1997), 308–312.